Overview

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

Status:
Active, not recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

This will be a single arm, window of opportunity study in men with treatment-naïve prostate cancer who will proceed to prostatectomy. Men will be treated with carvedilol prior to undergoing prostatectomy.

Phase:

Phase 2

Details

Lead Sponsor:

Montefiore Medical Center

Collaborators:

Albert Einstein College of Medicine
Albert Einstein College of Medicine of Yeshiva University

Treatments:

Adrenergic Agents
Carvedilol